Stocktoria
Kraig Biocraft Laboratories, Inc. KBLB
OTC · stock · Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · website · IPO 2008-02-29
Kraig Biocraft Laboratories, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $401,620 | $97,318 | $31,858 |
| R&D expense | $165,758 | $164,374 | $237,871 | $176,431 | $197,745 | $88,470 | $223,050 | $148,069 | $258,892 | $397,136 |
| Operating income | -$3.4M | -$3.1M | -$2.6M | -$2.1M | -$2.8M | -$4.5M | -$2.6M | -$959,947 | -$2.2M | -$2.9M |
| Interest expense | — | — | — | — | — | — | $294,352 | $228,954 | $177,105 | $139,430 |
| Income tax | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Net income | -$3.6M | -$3.4M | -$3.0M | -$3.8M | -$8.0M | -$5.0M | -$2.9M | -$1.2M | -$2.3M | -$3.1M |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |
| Operating cash flow | -$1.8M | -$1.8M | -$1.2M | -$1.9M | -$1.8M | -$1.3M | -$1.1M | -$235,005 | -$729,542 | -$1.0M |
| Free cash flow | -$1.8M | -$1.8M | -$1.3M | -$1.9M | -$1.9M | — | -$1.2M | -$246,453 | -$760,709 | -$1.0M |
| Cash & equivalents | $1.8M | $673,264 | $2.6M | $3.9M | — | — | — | $13,697 | $18,150 | $298,859 |
| Inventory | $29,067 | $6,884 | $6,884 | $6,580 | — | — | — | — | — | — |
| Total assets | $2.6M | $1.5M | $3.2M | $4.6M | $3.0M | $1.3M | $750,850 | $71,383 | $114,499 | $383,659 |
| Total liabilities | $10.6M | $9.7M | $8.9M | $8.1M | $8.3M | $7.9M | $6.1M | $4.5M | — | $2.7M |
| Shareholders' equity | -$8.0M | -$8.1M | -$5.7M | -$3.5M | -$5.3M | -$6.6M | -$5.4M | -$4.5M | -$3.4M | -$2.4M |
Growth · year-over-year · Revenue CAGR 255.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | — | — | — | +312.7% | +205.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.